Echo Therapeutics, Inc. Announces Successful CFDA Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Echo Therapeutics (ECTE) Strategic Partner Holds Successful Meeting with China FDA
April 28, 2015 7:51 AM EDTEcho Therapeutics (NASDAQ: ECTE) announced that its strategic partner, Medical Technologies Innovation Asia (MTIA), Ltd., held a meeting with the Medical Device Evaluation Center of the China Food and Drug Administration (CFDA), Beijing Branch, on April 23, 2015 to define its strategy and clinical pathway for CFDA regulatory approval. Under the terms of Echo's collaboration agreement with MTIA, MTIA is responsible for obtaining regulatory approval for the product in the licensed territories, including the Peoples' Republic of China, Hong Kong, Macau and Taiwan.
Positive feedback from the meeting is assisting MTIA in executing its strategy... More
